» Authors » Georgeta Camelia Cozaru

Georgeta Camelia Cozaru

Explore the profile of Georgeta Camelia Cozaru including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Orasanu C, Aschie M, Deacu M, Bosoteanu M, Vamesu S, Enciu M, et al.
Diagnostics (Basel) . 2025 Feb; 15(4). PMID: 40002588
Brain tumors pose a significant health threat, leading to high morbidity and mortality rates. Astrocytoma IDH-mutant grade 4 (A4) and glioblastoma IDH-wildtype (G4I) exhibit similar clinical and imaging characteristics. This...
2.
Ghitoi S, Deacu M, Aschie M, Enciu M, Mitroi A, Cozaru G, et al.
Clin Pract . 2024 Sep; 14(5):1801-1817. PMID: 39311294
Preterm births comprise all pregnancies coming to an end before the gestational age of 37 weeks and remain the leading cause of death in children under 5 years old despite...
3.
Matei E, Ionescu A, Enciu M, Popovici V, Mitroi A, Aschie M, et al.
Medicine (Baltimore) . 2024 Sep; 103(37):e39450. PMID: 39287312
Tumor heterogeneity results in aggressive cancer phenotypes with acquired resistance. However, combining chemical treatment with adjuvant therapies that cause cellular structure and function perturbations may diminish the ability of cancer...
4.
Nurla L, Aschie M, Cozaru G, Bosoteanu M
Medicina (Kaunas) . 2024 May; 60(5). PMID: 38792946
The CDKN2A gene remains understudied in melanoma compared to BRAF alterations. Inactivation of this tumor suppressor gene through homozygous deletions in the 9p21 chromosomal region leads to cellular proliferation and...
5.
Nurla L, Gheorghe E, Aschie M, Cozaru G, Orasanu C, Bosoteanu M
Diagnostics (Basel) . 2024 Apr; 14(8). PMID: 38667459
Melanoma, a malignant neuroectodermic tumor originating from the neural crest, presents a growing global public health challenge and is anticipated to become the second most prevalent malignancy in the USA...
6.
Dumitru A, Matei E, Cozaru G, Chisoi A, Alexandrescu L, Popescu R, et al.
Int J Mol Sci . 2024 Mar; 25(5). PMID: 38473721
Our study highlighted the immune changes by pro-inflammatory biomarkers in the gut-liver-axis-linked ROS-cell death mechanisms in chronic and acute inflammations when gut cells are exposed to endotoxins in patients with...
7.
Caraban B, Aschie M, Deacu M, Cozaru G, Pundiche M, Orasanu C, et al.
Clin Pract . 2024 Feb; 14(1):214-241. PMID: 38391404
Cutaneous melanoma is a public health problem. Efforts to reduce its incidence have failed, as it continues to increase. In recent years, many risk factors have been identified. Numerous diagnostic...
8.
Bosoteanu L, Gheorghe E, Aschie M, Cozaru G, Deacu M, Baltatescu G, et al.
Medicina (Kaunas) . 2023 Dec; 59(12). PMID: 38138255
: In the realm of the rising incidence of cutaneous and mucous melanoma, CDKN2A mutations characterize familial and multiple primary melanoma cases. The involvement of tumor-infiltrating lymphocytes (TILs) is interconnected...
9.
Bosoteanu L, Gheorghe E, Aschie M, Cozaru G, Deacu M, Orasanu C, et al.
Medicine (Baltimore) . 2023 Dec; 102(51):e36756. PMID: 38134090
Melanoma represents an aggressive malignant tumor, encapsulating frequent loss of differentiation markers, with familial melanoma constituting a relatively commonly encountered entity, in direct relationship with cyclin-dependent kinase inhibitor 2A (CDKN2A)....
10.
Deacu M, Bosoteanu M, Enciu M, Cozaru G, Cojocaru O, Baltatescu G, et al.
Diagnostics (Basel) . 2023 Dec; 13(24). PMID: 38132190
Lipomatous tumors are the most frequent soft tissue neoplasms. Sometimes their differential diagnosis is difficult to perform only by microscopic analysis. This study aims to create a histopathological scoring system...